A NOVEL LOW-DOSE COMBINATION DRUG THERAPY FOR ENDOMETRIOSIS THAT INCREASES PROGESTERONE RECEPTOR TO ENHANCE PROGESTIN EFFICACY
OA: bronze
CC0
AI-generated summary
This paper describes a new low-dose drug combination therapy for endometriosis that increases progesterone receptor expression to improve progestin treatment effectiveness.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (11)
- Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study--Part 1 via openalex
- Changing trends in the diagnosis of endometriosis: a comparative study of women with pelvic endometriosis presenting with chronic pelvic pain or infertility via openalex
- Clinical diagnosis of endometriosis: a call to action via openalex
- Diagnostic Delay of Endometriosis in the Netherlands via openalex
- IMPACT OF ENDOMETRIOSIS ON SEXUAL LIFE OF WOMEN AND PARTNERS: RESULTS FROM THE ENDOVIE SURVEY via openalex
- Pointers to earlier diagnosis of endometriosis: a nested case-control study using primary care electronic health records via openalex
- Risk factors associated with endometriosis: importance of study population for characterizing disease in the ENDO Study via openalex
- Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women via openalex
- W2921518676 via openalex
- W6689135859 via openalex
- W6757289468 via openalex
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK